SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-163324
Filing Date
2017-05-09
Accepted
2017-05-09 06:14:03
Documents
4
Period of Report
2017-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d583046d8k.htm 8-K 16102
2 EX-99.1 d583046dex991.htm EX-99.1 36253
3 GRAPHIC g583046g0504090439352.jpg GRAPHIC 4394
4 GRAPHIC g583046g0504090439508.jpg GRAPHIC 3304
  Complete submission text file 0001193125-17-163324.txt   64549
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 17824340
SIC: 2834 Pharmaceutical Preparations